Acquiring a company can accelerate growth and momentum, allowing a startup to expand faster without draining core resources.

Taking advantage of high-leverage activities that larger companies might avoid can be a key strategy for startups to differentiate themselves.

Successful biotech funds often incubate ideas internally before spinning them out as independent companies, which has proven effective in the industry.

You can build a better business by staying private for longer, as we're starting to see the evolution of large companies facilitating secondary rounds.

Joining a larger company can feel like skipping from seed stage to series B, but it also offers opportunities to learn new skills and lead at a larger scale.

In fundraising, securing a top-tier investor who adds value can be worth millions to your company's valuation, as seen with Airbnb's experience.

Innovating in corporate governance, such as choosing unusual incorporation methods, is often misguided and can lead to complications that distract from the main goal of creating a valuable product.

Investors often chase opportunities in startups, hoping to profit from future growth, which can lead to inflated valuations that may not be sustainable.

Despite some companies being overvalued, the overall ecosystem benefits as it allows for easier capital raising, which can accelerate innovation and growth across the industry.